These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29949195)

  • 41. Brain derived neurotrophic factor (BDNF) and autism spectrum disorders (ASD) in childhood.
    Bryn V; Halvorsen B; Ueland T; Isaksen J; Kolkova K; Ravn K; Skjeldal OH
    Eur J Paediatr Neurol; 2015 Jul; 19(4):411-4. PubMed ID: 25847750
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Amino Acid Dysregulation Metabotypes: Potential Biomarkers for Diagnosis and Individualized Treatment for Subtypes of Autism Spectrum Disorder.
    Smith AM; King JJ; West PR; Ludwig MA; Donley ELR; Burrier RE; Amaral DG
    Biol Psychiatry; 2019 Feb; 85(4):345-354. PubMed ID: 30446206
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incontinence in children with autism spectrum disorder.
    von Gontard A; Pirrung M; Niemczyk J; Equit M
    J Pediatr Urol; 2015 Oct; 11(5):264.e1-7. PubMed ID: 26052001
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduced endogenous urinary total antioxidant power and its relation of plasma antioxidant activity of superoxide dismutase in individuals with autism spectrum disorder.
    Yui K; Tanuma N; Yamada H; Kawasaki Y
    Int J Dev Neurosci; 2017 Aug; 60():70-77. PubMed ID: 27554135
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neonatal Cytokine Profiles Associated With Autism Spectrum Disorder.
    Krakowiak P; Goines PE; Tancredi DJ; Ashwood P; Hansen RL; Hertz-Picciotto I; Van de Water J
    Biol Psychiatry; 2017 Mar; 81(5):442-451. PubMed ID: 26392128
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vitamin A improves the symptoms of autism spectrum disorders and decreases 5-hydroxytryptamine (5-HT): A pilot study.
    Guo M; Zhu J; Yang T; Lai X; Liu X; Liu J; Chen J; Li T
    Brain Res Bull; 2018 Mar; 137():35-40. PubMed ID: 29122693
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acyl-carnitine, C5DC, and C26 as potential biomarkers for diagnosis of autism spectrum disorder in children.
    Lv QQ; You C; Zou XB; Deng HZ
    Psychiatry Res; 2018 Sep; 267():277-280. PubMed ID: 29945069
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low Serum Level α-Synuclein and Tau Protein in Autism Spectrum Disorder Compared to Controls.
    Kadak MT; Cetin I; Tarakçıoğlu MC; Özer ÖF; Kaçar S; Çimen B
    Neuropediatrics; 2015 Dec; 46(6):410-5. PubMed ID: 26479762
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [S100B protein in the blood of children with autism spectrum disorders].
    Golubova TF; Tsukurova L; Korsunskaya LL; Osipyan RR; Vlasenko SV; Savchuk EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(12):76-83. PubMed ID: 31994518
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High plasma neopterin levels in Chinese children with autism spectrum disorders.
    Zhao HX; Yin SS; Fan JG
    Int J Dev Neurosci; 2015 Apr; 41():92-7. PubMed ID: 25660944
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elevated levels of tissue plasminogen activator and E-selectin in male children with autism spectrum disorder.
    Şimşek Ş; Çetin İ; Çim A; Kaya S
    Autism Res; 2016 Dec; 9(12):1241-1247. PubMed ID: 27194368
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Social communication in children with autism spectrum disorder (asd): Correlation between DSM-5 and autism classification system of functioning-social communication (ACSF:SC).
    Craig F; Fanizza I; Russo L; Lucarelli E; Alessandro L; Pasca MG; Trabacca A
    Autism Res; 2017 Jul; 10(7):1249-1258. PubMed ID: 28266789
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum Ischemia-Modified Albumin Levels, Myeloperoxidase Activity and Peripheral Blood Mononuclear cells in Autism Spectrum Disorder (ASD).
    Ceylan MF; Tural Hesapcioglu S; Yavas CP; Senat A; Erel O
    J Autism Dev Disord; 2021 Jul; 51(7):2511-2517. PubMed ID: 33029667
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessment of BDNF serum levels as a diagnostic marker in children with autism spectrum disorder.
    Barbosa AG; Pratesi R; Paz GSC; Dos Santos MAAL; Uenishi RH; Nakano EY; Gandolfi L; Pratesi CB
    Sci Rep; 2020 Oct; 10(1):17348. PubMed ID: 33060610
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of vitamin A supplementation on gut microbiota in children with autism spectrum disorders - a pilot study.
    Liu J; Liu X; Xiong XQ; Yang T; Cui T; Hou NL; Lai X; Liu S; Guo M; Liang XH; Cheng Q; Chen J; Li TY
    BMC Microbiol; 2017 Sep; 17(1):204. PubMed ID: 28938872
    [TBL] [Abstract][Full Text] [Related]  

  • 56. GABA synaptopathy promotes the elevation of caspases 3 and 9 as pro-apoptotic markers in Egyptian patients with autism spectrum disorder.
    El-Ansary A; Zayed N; Al-Ayadhi L; Qasem H; Anwar M; Meguid NA; Bhat RS; Doşa MD; Chirumbolo S; Bjørklund G
    Acta Neurol Belg; 2021 Apr; 121(2):489-501. PubMed ID: 31673995
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum thyroid-stimulating hormone and interleukin-8 levels in boys with autism spectrum disorder.
    Singh S; Yazdani U; Gadad B; Zaman S; Hynan LS; Roatch N; Schutte C; Marti CN; Hewitson L; German DC
    J Neuroinflammation; 2017 Jun; 14(1):113. PubMed ID: 28577577
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alterations in plasma cytokine levels in chinese children with autism spectrum disorder.
    Hu CC; Xu X; Xiong GL; Xu Q; Zhou BR; Li CY; Qin Q; Liu CX; Li HP; Sun YJ; Yu X
    Autism Res; 2018 Jul; 11(7):989-999. PubMed ID: 29522267
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum levels of glial fibrillary acidic protein and Nogo-A in children with autism spectrum disorders.
    Cetin I; Tezdig I; Tarakcioglu MC; Kadak MT; Demirel OF; Ozer OF
    Biomarkers; 2016 Nov; 21(7):614-8. PubMed ID: 27097671
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased serum levels of glutamate in adult patients with autism.
    Shinohe A; Hashimoto K; Nakamura K; Tsujii M; Iwata Y; Tsuchiya KJ; Sekine Y; Suda S; Suzuki K; Sugihara G; Matsuzaki H; Minabe Y; Sugiyama T; Kawai M; Iyo M; Takei N; Mori N
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1472-7. PubMed ID: 16863675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.